[go: up one dir, main page]

BRPI0811035A2 - Composições de fibrina contendo compostos de estrôncio - Google Patents

Composições de fibrina contendo compostos de estrôncio

Info

Publication number
BRPI0811035A2
BRPI0811035A2 BRPI0811035-2A2A BRPI0811035A BRPI0811035A2 BR PI0811035 A2 BRPI0811035 A2 BR PI0811035A2 BR PI0811035 A BRPI0811035 A BR PI0811035A BR PI0811035 A2 BRPI0811035 A2 BR PI0811035A2
Authority
BR
Brazil
Prior art keywords
fibrine
compositions containing
containing stress
stress compounds
compounds
Prior art date
Application number
BRPI0811035-2A2A
Other languages
English (en)
Inventor
John J Barry
Andreas Goessl
Gerald Zimmer
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of BRPI0811035A2 publication Critical patent/BRPI0811035A2/pt
Publication of BRPI0811035B1 publication Critical patent/BRPI0811035B1/pt
Publication of BRPI0811035B8 publication Critical patent/BRPI0811035B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225Fibrin; Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/02Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/29Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/363Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4833Thrombin (3.4.21.5)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/446Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/502Plasticizers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Composite Materials (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Cell Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Botany (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0811035A 2007-04-23 2008-04-18 composições de fibrina contendo compostos de estrôncio BRPI0811035B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92571607P 2007-04-23 2007-04-23
US60/925,716 2007-04-23
PCT/US2008/060720 WO2008131154A2 (en) 2007-04-23 2008-04-18 Fibrin compositions containing strontium compounds

Publications (3)

Publication Number Publication Date
BRPI0811035A2 true BRPI0811035A2 (pt) 2014-10-21
BRPI0811035B1 BRPI0811035B1 (pt) 2018-07-31
BRPI0811035B8 BRPI0811035B8 (pt) 2021-05-25

Family

ID=39745302

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0811035A BRPI0811035B8 (pt) 2007-04-23 2008-04-18 composições de fibrina contendo compostos de estrôncio

Country Status (16)

Country Link
US (1) US20080260714A1 (pt)
EP (2) EP2142224B1 (pt)
JP (2) JP5907656B2 (pt)
KR (1) KR101520114B1 (pt)
CN (2) CN103785058B (pt)
AR (1) AR066245A1 (pt)
AU (1) AU2008242867B2 (pt)
BR (1) BRPI0811035B8 (pt)
CA (1) CA2686820C (pt)
CL (1) CL2008001171A1 (pt)
CO (1) CO6251232A2 (pt)
ES (2) ES2573327T3 (pt)
IL (1) IL201480A0 (pt)
MX (1) MX2009011268A (pt)
TW (1) TWI556842B (pt)
WO (1) WO2008131154A2 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1024250C2 (nl) * 2003-09-09 2005-03-10 Fluxxion B V Vervaardiging van een microzeef, en microzeef en inrichting met een microzeef.
CA2702190A1 (en) * 2007-10-12 2009-04-16 Kuros Biosurgery Ag Injectable radio-opaque compositions for tissue augmentation
ES2403057T3 (es) 2008-04-18 2013-05-13 Kuros Biosurgery Ag Dispositivo de suministro, kit que contiene el dispositivo, y método para operar el dispositivo
WO2010081037A1 (en) * 2009-01-08 2010-07-15 Numira Biosciences, Inc. Methods and compositions for imaging atherosclerotic plaques
WO2010081044A1 (en) * 2009-01-08 2010-07-15 Numira Biosciences, Inc. Methods and compositions for imaging cartilage and bone
JP5960051B2 (ja) * 2009-08-04 2016-08-02 プシロクス・エービーPsilox AB イオン置換リン酸カルシウム粒子
US8882740B2 (en) * 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
US8614190B2 (en) 2010-06-30 2013-12-24 Industrial Technology Research Institute Thermal responsive composition for treating bone diseases
WO2012024634A2 (en) * 2010-08-19 2012-02-23 University Of Washington Through Its Center For Commercialization Environmentally-responsive nanocomposites and methods of their use
JP5304939B1 (ja) * 2012-05-31 2013-10-02 大日本印刷株式会社 光学積層体、偏光板、偏光板の製造方法、画像表示装置、画像表示装置の製造方法及び画像表示装置の視認性改善方法
EP3122652A4 (en) * 2014-03-27 2017-12-13 Novabone Products, LLC Kit for delivering bone grafting materials
WO2015193836A1 (en) 2014-06-19 2015-12-23 Consiglio Nazionale Delle Ricerche (Cnr) Injectable apatitic cement ionically multi-substituted for regenerative vertebroplasty and kyphoplasty
US10238507B2 (en) 2015-01-12 2019-03-26 Surgentec, Llc Bone graft delivery system and method for using same
CN110198710A (zh) * 2016-12-09 2019-09-03 西北大学 骨促进性温敏大分子
US11116647B2 (en) 2018-04-13 2021-09-14 Surgentec, Llc Bone graft delivery system and method for using same
US10687828B2 (en) 2018-04-13 2020-06-23 Surgentec, Llc Bone graft delivery system and method for using same
WO2023129802A1 (en) 2021-12-30 2023-07-06 Baxter International Inc. Fibrinogen and thrombin solutions for a fibrin sealant and fibrin sealant kit
EP4467168A1 (en) * 2022-01-18 2024-11-27 Korea Institute of Science and Technology Apatite for filler and filler composition comprising same

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737411A (en) * 1986-11-25 1988-04-12 University Of Dayton Controlled pore size ceramics particularly for orthopaedic and dental applications
US4969888A (en) 1989-02-09 1990-11-13 Arie Scholten Surgical protocol for fixation of osteoporotic bone using inflatable device
IT1240938B (it) 1990-02-08 1993-12-27 S.E.I.P.I. Societa' Esportazione Importazione Prodotti Industriali Composizione vetrosa bioattiva per impianti ossei e prodotti ottenuti con tale composizione o che la comprendono
WO1991017777A2 (en) 1990-05-22 1991-11-28 University Of Florida Injectable bioactive glass compositions and methods for tissue reconstruction
JPH0662381B2 (ja) * 1990-06-26 1994-08-17 昭和薬品化工株式会社 骨性硬組織形成用ペースト組成物
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
FR2705235B1 (fr) * 1993-05-13 1995-07-13 Inoteb Utilisation de particules d'un sel de calcium biocompatible et biorésorbable comme ingrédient actif dans la préparation d'un médicament destiné au traitement local des maladies déminéralisantes de l'os.
US5549904A (en) * 1993-06-03 1996-08-27 Orthogene, Inc. Biological adhesive composition and method of promoting adhesion between tissue surfaces
US6248110B1 (en) 1994-01-26 2001-06-19 Kyphon, Inc. Systems and methods for treating fractured or diseased bone using expandable bodies
US6241734B1 (en) 1998-08-14 2001-06-05 Kyphon, Inc. Systems and methods for placing materials into bone
FI101129B (sv) 1995-01-13 1998-04-30 Vivoxid Oy Nya bioaktiva glas och deras användning
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
AU4456597A (en) * 1996-09-18 1998-04-14 Basf Aktiengesellschaft Pyridine derivatives, process for preparing the same and their use for controlling animal pests and harmful fungi
JPH10236976A (ja) * 1997-02-26 1998-09-08 Chemo Sero Therapeut Res Inst 骨形成促進剤
US20010016646A1 (en) * 1998-03-20 2001-08-23 David C. Rueger Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
FR2772746B1 (fr) * 1997-12-23 2000-01-28 Commissariat Energie Atomique Procede de fabrication d'une ceramique apatitique, en particulier pour usage biologique
ES2207258T3 (es) * 1998-07-13 2004-05-16 University Of Southern California Procedimiento para acelerar el crecimiento oseo y del cartilago y su recuperacion.
DE19956503A1 (de) * 1999-11-24 2001-06-21 Universitaetsklinikum Freiburg Spritzbares Knochenersatzmaterial
NO20014746D0 (no) * 2001-09-28 2001-09-28 Clas M Kjoelberg Smertelindrende middel
SE522098C2 (sv) 2001-12-20 2004-01-13 Bone Support Ab Ett nytt benmineralsubstitut
AU2003218271A1 (en) * 2002-04-18 2003-11-03 Carnegie Mellon University Method of manufacturing hydroxyapatite and uses therefor in delivery of nucleic acids
US7273523B2 (en) * 2002-06-07 2007-09-25 Kyphon Inc. Strontium-apatite-cement-preparations, cements formed therefrom, and uses thereof
DE10225420A1 (de) * 2002-06-07 2003-12-24 Sanatis Gmbh Strontium-Apatit-Zement-Zubereitungen, die daraus gebildeten Zemente und die Verwendung davon
ATE322295T1 (de) 2002-10-03 2006-04-15 Vivoxid Oy Bioaktive glaszusammensetzung
WO2004098619A2 (en) * 2003-05-07 2004-11-18 Osteologix A/S Treating cartilage / bone conditions with water-soluble strontium salts
US6905723B2 (en) 2003-05-30 2005-06-14 Depuy Products, Inc. Strontium-substituted apatite coating
KR100531922B1 (ko) * 2003-12-23 2005-11-29 주식회사 셀론텍 연골치료제 조성물 및 그 사용방법
US20080167513A1 (en) * 2004-02-26 2008-07-10 Osteologlx A/S Strontium-Containing Compounds for Use in the Prevention or Treatment of Necrotic Bone Conditions
FR2869544B1 (fr) * 2004-05-03 2006-07-21 Centre Nat Rech Scient Cnrse Composition pour ciment injectable, utile comme substitut osseux
CA2571449C (en) * 2004-06-25 2015-12-08 John Nikolaj Hvarre Christensen Compositions comprising strontium and vitamin d and uses thereof
EP1655042A1 (en) 2004-11-02 2006-05-10 Vivoxid Oy A medical device
EP1833522B1 (en) * 2005-01-06 2016-06-22 Kuros Biosurgery AG Supplemented matrices for the repair of bone fractures
US20060216321A1 (en) * 2005-03-24 2006-09-28 Sdgi Holdings, Inc. Solvent based processing technologies for making tissue/polymer composites
CN1846789A (zh) * 2005-04-14 2006-10-18 南方医院 一种注射型骨修复材料及其制备与应用
PL2021043T3 (pl) * 2006-05-26 2011-06-30 Baxter Int Wstrzykiwalny wypełniacz pustych przestrzeni w kościach
AU2007268175B2 (en) * 2006-05-26 2013-05-23 Baxter Healthcare S.A. Injectable fibrin composition for bone augmentation
DE602006011323D1 (de) * 2006-09-20 2010-02-04 Inion Oy Bioaktive Glaszusammensetzungen

Also Published As

Publication number Publication date
BRPI0811035B1 (pt) 2018-07-31
CN103785058A (zh) 2014-05-14
WO2008131154A3 (en) 2008-12-24
CA2686820C (en) 2016-06-28
EP2142224B1 (en) 2016-03-23
ES2594081T3 (es) 2016-12-15
EP2142224A2 (en) 2010-01-13
HK1205961A1 (en) 2015-12-31
US20080260714A1 (en) 2008-10-23
JP5907656B2 (ja) 2016-04-26
MX2009011268A (es) 2009-11-02
JP2010525070A (ja) 2010-07-22
CN101668549B (zh) 2014-04-09
KR20100017158A (ko) 2010-02-16
AU2008242867A1 (en) 2008-10-30
KR101520114B1 (ko) 2015-05-13
TWI556842B (zh) 2016-11-11
CN103785058B (zh) 2016-12-07
JP2013216678A (ja) 2013-10-24
IL201480A0 (en) 2010-05-31
JP6012551B2 (ja) 2016-10-25
CN101668549A (zh) 2010-03-10
BRPI0811035B8 (pt) 2021-05-25
ES2573327T3 (es) 2016-06-07
EP2823829A1 (en) 2015-01-14
EP2823829B1 (en) 2016-07-20
CA2686820A1 (en) 2008-10-30
CL2008001171A1 (es) 2008-11-03
AR066245A1 (es) 2009-08-05
WO2008131154A2 (en) 2008-10-30
AU2008242867B2 (en) 2014-01-23
CO6251232A2 (es) 2011-02-21
TW200902096A (en) 2009-01-16

Similar Documents

Publication Publication Date Title
BRPI0811035A2 (pt) Composições de fibrina contendo compostos de estrôncio
FR18C1052I2 (fr) Compositions fongicides
CY2017007I2 (el) Συνθεσεις που περιεχουν ενωσεις τεταρτοταγους αμμωνιου
BRPI0922959A8 (pt) composições herbicidas contendo compostos de benzoilpirazol
BRPI0914746A2 (pt) composições fungicidas
DK2185567T3 (da) Substituerede bicyclolactam-forbindelser
EP2280916A4 (en) HYDROCHLORFLUOROLEFINZUSAMMENSETZUNGEN
ATE528048T1 (de) Schweisshemmende/desodorierende zusammensetzung
DK2966175T3 (da) Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
BRPI0810557A2 (pt) composição
BRPI0811274A2 (pt) Composição
EP2197828A4 (en) FULLERENE MULTI-ADDUCT COMPOSITIONS
BRPI0811002A2 (pt) Composição biofertilizante
BRPI0820960A2 (pt) composição
EP2119430A4 (en) PERLENDE COMPOSITION
EP2188349A4 (en) OXYGEN ABSORBING COMPOSITION
BRPI0809270A2 (pt) Composição
BRPI0811860A2 (pt) Compostos de (fenil)imidazolil)metilheteroarila
EP2428566A4 (en) GENE TRANSFER AGENT COMPOSITION CONTAINING POLYAMIDOAMINE DENDRIMER
FR2921268B1 (fr) Composition sialagogue
EP2214697A4 (en) NELL-1 COMPOSITIONS
FI20060790A0 (fi) Parannetut koostumukset superkondensattoreita vartenº
BRPI0816144A2 (pt) Composição

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/04/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2771 DE 15-02-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.